Clinical trial
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
NCT01272102
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedMacular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Glaucomaverified · MONDO: glaucoma
Interventions
Sponsors & collaborators
Carl Zeiss Meditec, Inc.lead sponsor
DataMed Devices Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01272102 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.